user

Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study

被引：0
|
作者：
Tang, Huilin
Shaaban, C. Elizabeth
Wu, Yonghui
Magoc, Tanja
Donahoo, William T.
Dekosky, Steven T.
Bian, Jiang
Guo, Jingchuan
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-894-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
894-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of AKI in Older Adults with Type 2 Diabetes
    Zhuo, Min
    Paik, Julie M.
    Wexler, Deborah J.
    Bonventre, Joseph V.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 132 - 133
  • [32] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [33] New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study
    Cho, Yun Kyung
    Kim, Sehee
    Kim, Myung Jin
    Lee, Woo Je
    Kim, Ye-Jee
    Jung, Chang Hee
    DIABETES & METABOLISM, 2025, 51 (02)
  • [34] Correlation between the utilization of sodium-glucose cotransporter-2 (SGLT2) inhibitors and the risk of dementia: a nationwide population-based study in Taiwan
    Wu-Lung Chuang
    Stella Chin-Shaw Tsai
    Yi-Chun Yang
    Tsai-Ling Hsieh
    Heng-Jun Lin
    Yu-Han Huang
    Fuu-Jen Tsai
    Kuang-Hsi Chang
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, 398 (5) : 5835 - 5843
  • [35] Sodium-glucose co-transporter-2 inhibitors and the risk of ketoacidosis in patients with type 2 diabetes mellitus: A nationwide population-based cohort study
    Kim, Young-Gun
    Jeon, Ja Young
    Han, Seung Jin
    Kim, Dae Jung
    Lee, Kwan-Woo
    Kim, Hae Jin
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1852 - 1858
  • [36] Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Vivian, Eva
    DIABETES EDUCATOR, 2015, 41 : 5S - 18S
  • [37] The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes
    Steen, Oren
    Goldenberg, Ronald M.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 517 - 523
  • [38] Risk of hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Chang, Yoosoo
    Sinn, Dong Hyun
    Yu, Oriana Hoi Yun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 7 - 8
  • [39] Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
    Scheen, Andre J.
    NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (10) : 556 - 577
  • [40] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Population-Based Investigation
    Kwon, Osung
    Myong, Jun-Pyo
    Lee, Yunhee
    Choi, Yeon-Jik
    Yi, Jeong Eun
    Seo, Suk Min
    Jang, Sung-Won
    Kim, Pum Joon
    Lee, Jung-Min
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (14):
12345